Published
Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications
Published in November 2026 Issue 11 (Vol. 14, Issue 11, 2026)

Keywords
Abstract
Azoxymethane (AOM) is a synthetic alkylating procarcinogen widely employed in experimental pharmacology, toxicology and molecular oncology for investigating colorectal carcinogenesis. Although it does not possess an established therapeutic indication, its pharmacological and toxicological properties provide an important experimental framework for understanding chemical carcinogenesis and evaluating potential chemopreventive and anticancer interventions. Following metabolic activation, principally through cytochrome P450-dependent pathways, AOM generates methylating intermediates capable of producing DNA adducts, including O⁶-methylguanine. These alterations contribute to mutagenesis, epithelial dysregulation and colorectal tumour initiation. The combination of AOM with dextran sodium sulphate (DSS) has further established a reproducible experimental model of inflammation-associated colorectal cancer. This review examines the historical development, chemical characteristics, pharmacokinetic considerations, metabolic bioactivation, molecular mechanisms, cellular responses and toxicological profile of AOM. Particular attention is given to DNA damage, DNA repair mechanisms, KRAS and Wnt/β-catenin signalling, NF-κB activation, oxidative stress, NLRP3 inflammasome activity, apoptosis, autophagy and interactions with the intestinal microbiome. Contemporary applications in pharmacological research, including chemoprevention, natural-product evaluation, immunotherapy, microbiome-directed interventions and experimental drug screening, are discussed. Recent developments through 2026 highlight the importance of standardising AOM/DSS models and integrating microbiome, metabolomic and lipidomic investigations. The review concludes that AOM remains an important experimental carcinogenesis tool, provided its carcinogenic nature, model limitations and lack of direct therapeutic utility are recognised. Its principal translational value lies in facilitating the discovery and preclinical evaluation of safer and more effective colorectal cancer prevention and treatment strategies.
Authors (1)
Devansh Mehta
Independent Researcher and Sci...Independent Researcher and Scientific Writer, Meer...Independent Researcher and Scientific Writer, Meerut, Uttar Pradesh, I...Independent Researcher and Scientific Writer, Meerut, Uttar Pradesh, India.
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
November 2026 Issue 11 (Vol. 14, Issue 11, 2026)Article Impact
Views:2,924
Downloads:1,789
How to Cite
Mehta, D. (2026). Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications. American Journal of Pharmacy and Health Research, 14(11), 74-97. https://ajphr.com/articles/AJPHR11140000
Article Actions
More from this Issue
In Silico Evaluation of Gossypium Hirsutum Phytoconstituents against Gastric H+/K+-ATPASE
V.P.Rode, Aayush Pandit, ...Read more →
ASSESSMENT OF INTRAVENOUS HIGH-RISK MEDICATION MANAGEMENT IN A TERTIARY CARE HOSPITAL
Rajat Garg, Hemant Bhardw...Read more →
